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oes Percutaneous
oronary Intervention
ompromise the Outcome
f Subsequent Coronary
rtery Bypass Grafting?*
ichael Mack, MD
lano, Texas
ercutaneous coronary intervention (PCI) has traditionally
een used as first-line therapy for limited coronary artery
isease while coronary artery bypass grafting (CABG) has
een the mainstay of therapy for patients with more
dvanced multivessel and left main disease. With the more
requent use of PCI in patients with advanced and complex
isease, there is an increasing number of patients who
resent for CABG who have had previous PCI. A key factor
n this “PCI first” approach must be that the outcome of
ABG is not jeopardized by a prior PCI procedure(s). The
uestion therefore is when a patient who has had a previous
CI presents for CABG, is that patient at higher risk for
he surgical procedure and subject to worse long-term
utcomes than a similar patient presenting for CABG who
as not had previous PCI?
See page 758
It is the general sense of most practicing cardiac surgeons
hat many patients with 1 or especially multiple previous
CIs who present for CABG are, in fact, worse candidates
han they would have been before PCI. Every cardiac
urgeon can cite anecdotal cases of “full metal jackets” of
ong stenting in a vessel, making bypass either impossible or
uboptimal due to the necessity of placing a graft so distal in
vessel that graft patency and benefit from surgical revas-
ularization is compromised. Likewise, every surgeon has
een patients who presented with normal left ventricular
unction before an initial PCI only to present for CABG
ears later after multiple percutaneous interventions with a
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-
ions or the American College of Cardiology.o
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aquet Inc., Boston Scientific, and Cordis.ignificantly depressed left ventricular function. Whether
his is a detrimental effect of PCI or the result of progression
f native disease has been the subject of much debate and
onjecture. These anecdotal experiences are supported by
etrospective studies documenting that operative mortality
nd morbidity as well as survival are compromised in
atients undergoing CABG who have had a previous PCI
ompared with those who have not. This was first reported
n the pre-stent era and more recently with stents (1). The
argest report is from 2 Canadian centers showing that
atients with prior PCI had greater in-hospital mortality
odds ratio: 1.93, p  0.003) despite fewer comorbidities
2). Two subsequent single-center studies also support this
bservation. The first compared 2,626 patients with no prior
CI with 679 patients with prior PCI undergoing subse-
uent CABG and a sub-analysis comparing the impact of
rior PCI on 621 diabetic patients with triple-vessel disease
3,4). Both studies reported significantly worse early mor-
ality and adverse clinical events in patients with prior PCI.
ore recently, Chocron et al. (5) in a post hoc analysis of
he IMAGINE (Ischemia Management with Accupril
ost-bypass Graft via Inhibition of the coNverting Enzyme)
tudy found that in patients with left ventricular ejection
raction 40% having a history of PCI before surgery there
as a worse outcome post-CABG than in those with no
rior PCI (5).
There are a number of hypotheses as to why previous PCI
ay adversely affect outcomes with CABG (6). Patients
ay present with more advanced disease due to the bene-
cial effect of PCI in delaying surgery until later in life when
he disease has progressed. However, it may also be that
atients present in a more unstable clinical state. Another
eason can be compromise of left ventricular function and
oss of collateral circulation due to occlusion of side
ranches especially when “long stenting” is performed.
istal microembolization in the downstream vessel from
tents is another possible cause of left ventricular dysfunc-
ion. Endothelial dysfunction induced by stenting is a
nown occurrence, and it is possible that it could have an
dverse effect on adjacent graft patency. Furthermore, the
ecessity to bypass the coronary artery more distally where it
s smaller with more diffuse disease especially in patients
ith multiple stents rather than in the optimal target vessel
anding zone for a bypass more proximally can also be a
ause of worse outcomes after CABG. Periprocedural man-
gement and outcomes can be adversely affected by the now
niversal dual antiplatelet regimens in patients with stents
ho present for CABG. Excessive post-operative bleeding
n patients operated on with platelet inhibition and, con-
ersely, stent thrombosis with post-operative myocardial
nfarction in patients in whom the antiplatelet regimen has
een stopped before CABG are causes of early adverse
utcomes.
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Editorial Comment
766In this issue of the Journal, Yap et al. (7) retrospectively
eviewed outcomes after CABG in 13,184 patients of whom
1% had a previous PCI over a 7-year period in 6 hospitals
nd in an additional 8 hospitals during the last year of study.
t is unclear whether the length of follow-up was similar in
he 2 different population groups. Contrary to previously
ublished series, they found that prior PCI was not a risk
actor for unadjusted or adjusted short- or mid-term mor-
ality at a mean of 3.3 years after CABG. So how does one
econcile this conflicting information with that from the
reviously published studies as well as the experience of
ost surgeons, and how should this guide us in clinical
ractice?
Although this is a meticulous study, there are a number of
imitations of information contained in the database and of
he study that preclude generalization of the results to other
linical practice settings. First, the study is a retrospective
nalysis of clinical practice in 2 states in Australia, which
ay not necessarily correlate with practice patterns in other
eographic areas. With a previous PCI having been per-
ormed in only 11% of patients undergoing CABG, which
s much less than one sees elsewhere, one would expect that
omplex stenting in more advanced disease was not often
erformed. Furthermore, we are given no information as to
he number of patients who had multiple previous PCI
rocedures or the proportion of patients who received
rug-eluting versus bare-metal stents, all of which may
ffect outcomes. We also do not have information on the
umber of patients who may have not have survived after
CI and therefore never received a CABG.
Therefore, despite the findings of this study, one should
till be cautious about the assumption that a PCI procedure
s “free” of cost regarding no added risk of undergoing
ubsequent CABG. All the shortcomings of a retrospective,
bservational study in a relatively small population are
resent. At this level of study, it is impossible to get tufficiently “granular” on patient-specific issues that may
ffect outcomes. For example, we have no information on
hether multiple repeat PCI procedures were performed
nd how frequently long stenting was used, both of which
re likely to compromise the short- and long-term outcomes
f a subsequent surgical operation. Common sense dictates
hat, as with most things in life, moderation is the key and
othing replaces good clinical judgment on an individual
atient level.
eprint requests and correspondence: Dr. Michael Mack, Heart
ospital Baylor Plano, 1100 Allied Drive, Plano, Texas 75075.
-mail: mmack@csant.com.
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